Germline transcription has been described for both immunoglobulin and T-cell receptor (TCR) genes, raising questions of their functional significance during haematopoiesis. Previously, an immature murine T-cell line was shown to bind antibody to TCR-Vb8.2 in absence of anti-Cb antibody binding, and an equivalent cell subset was also identified in the mesenteric lymph node. Here, we investigate whether germline transcription and cell surface Vb8.2 expression could therefore represent a potential marker of T-cell progenitors. Cells with the TCR phenotype of Vb8. 
Introduction
Germline transcription is the production of mRNA transcripts from either the unrearranged T-cell receptor (TCR) or immunoglobulin (Ig) loci that are in 'germline' configuration. A common view has been that production of germline transcripts is tightly coupled to rearrangement events that take place at these loci to produce a functional TCR or B-cell receptor (BCR). By this scenario, one would expect germline transcripts to be produced at VDJ recombination when the chromatin is open and fully accessible to transcriptional machinery. However, germline TCR-Vb transcripts have been identified in early murine T cells well before the TCR-Vb rearrangement event in RAG À/À mice where no TCR rearrangement occurs [1] [2] [3] , and in cell subsets and cell lines expressing fully rearranged TCR genes [2, 4, 5] . This evidence refutes a model that associates germline transcription uniquely with the TCR rearrangement event. In addition, germline transcripts are generally thought to be sterile and non-functional. However, earlier antibody binding experiments have suggested that these transcripts encode and present a truncated TCR-Vb molecule on the cell surface in the absence of a Cb region. Cells of the C1-V13D line bind antibody to Vb8.2 but not Cb [2] . A small subset of cells with the Vb8.2 + Cb À phenotype was later identified in the mesenteric lymph node of DBA/2J mice (~4%). This was strain specific with a lower 1.4% found in SJL/J mice [6] .
Several unusual TCR and Ig receptor structures have been identified as evidence of germline-encoded proteins and novel TCR structures. For example, germline-encoded IgV H proteins have been reported [7] . Dual expression of TCRab structures functionally responsive to Staphylococcus enterotoxin B have been identified in mice [8] and humans [9, 10] . Dual TCRc chain receptor expression has also been reported [11] , along with cell surface expression of a rearranged TCR-Vb chain in the absence of pTa or CD3 [12] . TCR-Vb expression can occur on the cell surface as a structure differing from the conventional TCRab receptor.
The expression of germline TCR-Vb8 transcripts has been documented in both early B and T-cell subsets and cell lines like C1-V13D [4, 6] . In mice, germline-encoded TCR-Vb is detectable in multiple lymphoid tissues including mesenteric lymph node, spleen, thymus and bone marrow (BM) [13] . While in vivo subsets expressing Vb8 but not Cb determinants have been identified, there is little known about them. The developmental changes reported to occur in C1-V13D cells following intrathymic passage suggest that this cell line represents immature lymphoid cells that can differentiate along the T-cell lineage. Since germline transcripts occur during early lymphopoiesis [1, 4] , an important question is whether germline transcription and germline-encoded TCR proteins represent markers of T lymphoid lineage commitment. Here, we investigate the presence of Vb8 + Cb À cells in mouse thymus, BM, lymph node and spleen. The subset of lineage (Lin) À Vb8 + Cb À cells in BM has been further analysed for expression of markers which define hematopoietic progenitors, and their capacity to differentiate and produce T-cell progeny upon adoptive transfer in mice. While we found no evidence of T-cell reconstitution, the lymphoid characteristics of this progenitor subset were supported by specific production of mature B cells in spleen.
Materials and methods

Animals and tissue isolation
C57BL/Ka and C57BL/Ka-Thy1.1 (BA) mice expressing either Ly5.1 or Ly5.2 were bred and maintained in Research Animal Facility at Stanford University according to approved protocols. Male and female mice were used at 4-8 weeks of age. Mice were killed by CO 2 asphyxiation. Spleen, thymus and BM were aseptically removed from 5 to 10 mice for preparation of cell suspensions. For isolation of hematopoietic cells from BM, femur and tibia of hind legs were removed, excess tissue discarded, and the bones crushed in a small volume of medium PBS/2% fetal calf serum. Additional medium was added until all BM cells were released away from bone fragments.
Cell surface antibody staining
Spleen, thymus and lymph node cells were dissociated, and the cell suspension filtered through nylon mesh. Red blood cells were removed using lysis buffer (150 mM NH 4 Cl, 100 mM KHCO 3 , 0.1 mM Na 2 EDTA, pH 7.2-7.4) followed by washing in PBS/2%FCS. Cells were stained with antibody either directly with fluorochrome-conjugated antibodies, or indirectly with a purified antibody followed by a second stage conjugate. Antibodies and their specificity are shown: TCR-Vb8.1/8.2 (MR5.2), TCR-Cb (H57-597), Thy1.1 (19EX5), NK1.1 (PK136), B220 (RA3-6B2), Ly5.1 (ALI-4A2), Ly5.2 (A20.1.7), CD127 (A7R34), Sca-1 (E13-161-7), c-Kit (2B8), CD4 (GK1.5), CD8 (53-6.7), CD3e (KT31.1), TCRcd (GL3), I-A b (AF6-120.1), CD11c (HL3), CD44 (IM7), CD25 (7D4), CD19 (MB19-1), Mac-1 (M1/70) and Gr-1 (8C5). All antibodies were purified from hybridoma culture supernatants with the exception of antibodies specific for CD11c, CD25, CD44, TCRcd, I-A b , NK1.1, TCR-Cb, TCR-Vb8.1/8.2 and Ter119 purchased from BD Biosciences Pharmingen (San Jose, CA, USA). Anti-CD19 antibody was purchased from eBiosciences (San Diego, CA, USA). Secondary antibody conjugates used included Streptavidin-PE and Streptavidin-Cy7PE from Invitrogen (Carlsbad, CA, USA).
Following staining, cells were resuspended in PBS/2%FCS containing 1 lg/ml of propidium iodide (PI) to detect dead cells by flow cytometry. Normal BM cells were stained to set PI gates for sorted and depleted BM subsets. Cells were analysed for up to 5-colour staining using a FACS Vantage SE (Becton Dickinson, San Jose, CA, USA), and CellQuest Pro software (Becton Dickinson). Viable cells (PI À ) were gated using side scatter (SSC), and investigated for marker expression or sorted for cell subset isolation. For isolation of rare cell subsets, sorted cells were checked flow cytometrically and resorted to ensure high purity. 
Lineage depletion of cells
In vivo differentiation studies
To test whether Lin À Vb8 + Cb À cells in BM contained T-cell progenitors, sorted cells were adoptively transferred in vivo and their progeny developing in spleen and thymus assessed. BM cells of Lin À Vb8 + Cb À phenotype which had been sorted and resorted from BA(Ly5.1) mice were injected into C57BL/Ka-Ly5.2 sub-lethally irradiated hosts (4.75 Gy). Mice were given 500 cells either (a) intravenously through the orbital plexus, or (b) intrathymically, into a single thymic lobe [14] . Control mice were given either hematopoietic stem cells (HSC; Kit
À Cb À cells, also sorted out of BM. Post transplantation, mice were maintained on water containing polymyxin B sulphate (10 6 U/ml) and neomycin sulphate (1.1 g/l). Mice were killed at 4 weeks, and cells stained with antibodies to detect hematopoietic cell types among donor-derived progeny. This time was chosen as a compromise between time for detection of T-cell progeny of common lymphoid progenitors (CLP) which occurs between 14 and 28 days [15] , and for early development of T cells from hematopoietic stem cells or multipotential progenitors (MPP) which can be detected from as early as 3 weeks [16] .
Results
Characterization of Vb8
+ Cb
À cells in lymphoid tissues
The prevalence of Vb8 
B220
À cells, reflecting 0.05% of total mesenteric lymph node (Fig. 1) . In BM, a smaller Vb8 + B220
À population (0.5%) was identified ( Fig. 1 À subset in BM and other hematopoietic progenitor subsets was investigated flow cytometrically. Subsets in spleen were also analysed since the spleen is the source of the C1-V13D cell line, and contains hematopoietic stem/progenitor cells [22] . Common lymphoid progenitors, distinguishable as cKit lo Sca-1 lo CD127(IL-7Ra) + cells [15] , reflect the proximate source of T-cell progenitors in BM [23] . MPP as c-Kit hi Sca-1 hi CD127 À cells in BM also reflect a source of T-cell progenitors [24] , in that they can seed BM where they develop into CLP and later produce T cells in thymus [23] . On the basis of our hypothesis that Vb8 
Vb8
À Cb À subset containing HSC and MPP was sorted and served as a positive control for reconstitution. At 4 weeks post-transfer, mice were killed and both splenocytes and thymocytes collected and stained with antibodies specific to detect the presence of cells of different hematopoietic lineages.
Adoptively transferred cells developing in spleen and thymus of the Ly5.2 hosts were first identified as viable (PI À ) and then assessed for expression of Ly5.1 and lineage markers. Control Ly5.2 mice given PBS showed no staining for Ly5.1 (Table 1) . Markers used to detect cell development in thymus were specific for early progenitors (c-Kit), immature T cells (CD44 and CD25), . Figure 3 shows the staining profile of thymocytes for one representative animal. Cell development in spleen was assessed in terms of the frequency of donor-derived T cells (Cb, CD4, CD8), B cells (CD19), macrophages (Mac1) and granulocytes (Gr-1). Figure 4 shows the staining profile of splenocytes in one representative animal.
Mice intrathymically injected with control HSC (KLS) cells showed full reconstitution of every cell lineage common to spleen or thymus as anticipated (Figs 3 and 4, (Fig. 3) . The presence of low numbers of B220 + B cells developing in the thymus of mice given KLS cells (0.03%) has been reported previously [25, 27] . Amongst mice given Lin opment in spleen with no evidence of T cell or myeloid development in that organ (Fig. 4) . Since CD19 is a marker of both early B cells and more mature B cells, there results are consistent with Lin À Vb8 + Cb À cells containing a restricted B lymphoid progenitor that can develop in spleen following intravenous transfer, and can also localize in spleen following intrathymic transfer (Table 1) . This result contradicts our conclusion in Figure 2 , that the Vb8 + Cb À subsets in spleen could contain multipotent hematopoietic progenitors, and instead appears to contain specifically B-cell progenitors.
For mice given Lin À Vb8 + Cb À BM cells, the absence of T-cell production precludes the presence of T-cell progenitors among this subset. The absence of myeloid cell development in spleen also precludes the presence of HSC or MPP among this subset. The production of B cells and their localization in spleen but not thymus is also consistent with evidence of Vb8 + B220
+ cells in peripheral mesenteric lymph node and spleen but not thymus (Fig. 1) . Since Lin 
Discussion
Here, the hypothesis is investigated that Vb8 + Cb À cells in BM represent T-cell progenitors and that the expressed Vb8 peptide encoded from germline genes is a marker of these cells. Vb8
were identified in several organs including thymus, mesenteric lymph nodes, BM and spleen of mice. To some extent these subsets resemble C1-V13D, described previously as an immature spleen-derived T-cell line expressing TCR-Vb8.2 peptides as well as germline Vb8.2 transcripts [28] . The Vb8 BM revealed multiple sub-populations phenotypically resembling HSC, MPP, CMP and CLP.
The hypothesis that the Vb8 + Cb À subset contains lymphoid progenitors was based on transcriptional evidence that both early T and B cells express GL-Vb8.2 transcripts [4, 6] . Following both intrathymic and intravenous transfer of Lin Results presented here contrast with previous evidence that the C1-V13D cell line, representing a splenic Vb8 + Cb À cell line, can undergo some T-cell differentiation upon intrathymic transfer showing TCRab expression [28] . It is possible that the Lin
À subset from BM contains lymphoid progenitors with capacity to differentiate into only B cells, while a similar or equivalent subset resident in spleen may have T-cell differentiative potential. Such a model invokes a heterogeneous population of progenitors in mice expressing germline Vb8 peptide. This is supported by evidence for expression of GL-Vb8.2 transcripts in many cell types including early T cells, early B cells, BM progenitors and early dendritic cells (Abbey & O'Neill, unpublished data). Indeed, C1-V13D has been shown to express low levels of early T-cell markers including CD3e [28] . It is also important to note that lineage depletion using anti-CD3e antibody would also deplete CLP known to express this marker [15] . However, depletion with anti-Thy1.1 did not reveal a CLP with T-cell differentiative capacity even after intrathymic inoculation. The Lin
À BM subset therefore appears to contain a later lymphoid progenitor committed to the B-cell lineage.
The Lin À Vb8 + Cb À BM population does not appear to contain bipotent CLP-like cells with capacity to differentiate into both T and B cells. In terms of bipotent lymphoid potential, thymic DN1 cells are known to be heterogeneous with specific sub-populations retaining ability to give rise to B cells [30] . While bipotent T and B progenitors can give rise to B cells in thymus, this does not appear to be the case for the Lin [27, 29] . In fact, the progenitor described here appears to have properties more closely resembling the CLP-2 cell type, which can seed thymus and differentiate into B cells [31] . However since the Lin
À cell subset does not express B220, it is distinct from the CLP-2 population identified in BM as a B220 + cell [31] . Mesenteric lymph nodes may also be an important source of Vb8 + Cb À cells [12] . Mesenteric lymph nodes have also been described as a site for extra-thymic T-cell development [17] [18] [19] [20] [21] . Consistent with this evidence is the finding that subsets of Vb8 + Cb À
B220
+ cells exist in BM (0.07%) and mesenteric lymph node (0.12%) of BA mice, but not in spleen and thymus (Fig. 1) 
+ subsets detectable in these tissues and the B-cell populations produced in reconstitution studies also needs to be addressed further.
Evidence for germline transcription of TCR-Vb genes leading to expression of a cell surface peptide in B-cell progenitors raises questions of their functional role. Models for function should take into account the prevalence of Vb8 peptide-expressing cells in multiple organs, and in both mature and immature lymphoid cells. Many attempts to investigate cell surface expression of germline TCRVb8.2 expression on the surface of TCR-Cb À cells by immunoprecipitation and Western blotting have been unsuccessful. Preliminary experiments have shown that this protein is not GPI-anchored on the cell surface (Abbey & O'Neill, unpublished data). It is possible that a truncated TCR-b chain with no transmembrane region is expressed only and then is secreted by cells. Such transitional expression could also account for the variable expression reported for TCR-Vb8.2 on the surface of C1-V13D cells [2] . Transfection of germline TCR-Vb8.2 genes into C1-V13D cells was used to overcome this problem in demonstrating cell surface expression [32] . Candidate molecules that could be involved in a cell surface complex with TCR-Vb8.2 could include pTa and CD3e, each of which is expressed by C1-V13D (Abbey & O'Neill, unpublished data).
One possible role for germline-encoded TCR-Vb peptides could be generation of tolerance to T cells in vivo. A substantial level of diversity exists within the TCR and BCR repertoire against which developing T and B lymphocytes must be tolerized. Therefore, germline-encoded Ig or TCR proteins may play an antigenic role in this process within thymus for T-cell development, or within BM, spleen and lymph node for B-cell development. The expression of multiple germline TCR-Vb transcripts in the cloned C1-V13D cell line also supports this model [5] .
